| 6:45 a.m. |
Registration |
| 7:30 a.m. |
Introduction by Moderators |
| 7:35 a.m. |
2020 Harry Hirsch Leiter Award Recipient:
The Efficacy of Riboflavin Versus Rose Bengal Photodynamic Antimicrobial Therapy on South Florida Nocardia Keratitis Isolates
Ethan Adre |
| 7:42 a.m. |
1. The Impact of Non-Infectious Uveitis and Systemic Corticosteroid Use On COVID-19 Outcomes
Idara Akpandak |
| 7:49 a.m. |
2. Are COVID-19 Antivirals Active against Adenovirus?
Eric G. Romanowski, MS |
| 7:56 a.m. |
3. Investigating Practice Patterns of Zoster Sine Herpete in the Zoster Eye Disease Study Group
George Sanchez, BS |
| 8:03 a.m. |
4. Herpes Zoster Ophthalmicus: Incidence and Risk Factors for Developing Severe Ocular Manifestations
Aidan Dmitriev, BS |
| 8:10 a.m. |
5. Population Structure of Ocular Streptococcus pneumoniae is Highly Diverse and Formed by Lineages that Escape Current Vaccines
Paulo J.M. Bispo |
| 8:17 a.m. |
6. Genome Analysis of Viridans Group Streptococcus Strains from Endophthalmitis
Mary E. Marquart, PhD |
| 8:24 a.m. |
7. Enterotoxins Promote Staphylococcus aureus Virulence in Corneal Infections
Rachel Wozniak, MD, PhD |
| 8:31 a.m. |
8. Vitamin A Deficiency: A Consideration When Evaluating Patients with Potential Microbial Keratitis
Ayodele K. Maja, BA |
| 8:38 a.m. |
9. Targeted Mass Azithromycin Distribution for Trachoma: A Community-Randomized Trial (TANA II)
Hamidah Mahmud |
| 8:45 a.m. |
10. The C-DU(KE) Calculator: A Novel Tool for Risk Stratification in Infectious Keratitis
Hazem M. Mousa, MD |
| 8:52 a.m. |
11. Novel Molecular Barcoding for Rapid Pathogen Detection in Infectious Keratitis
Lawson Ung, MD, SM |
| 8:59 a.m. |
OPEN QUESTIONS AND COMMENTS |
| 9:05 a.m. |
12. Muramyl Dipeptide Cleaved by Human Corneal Epithelial Cell N-Acetylmuramoyl-L-Alanine Amidase (NAMAA) Retain Cytopathic Activity
Marlyn P. Langford, PhD |
| 9:12 a.m. |
13. Deep Learning for Image-Based Differentiation of Bacterial and Fungal Keratitis
Travis K. Redd, MD, MPH |
| 9:19 a.m |
14. Automated Quantification of Activated Dendritic Cells in Central Cornea
Katherine D. Leviste, MS |
| 9:26 a.m. |
15. Rose Bengal Photodynamic Antimicrobial Therapy: A Review of The Long-Term Clinical and Surgical Outcomes Following Keratoplasty
Paula A. Sepulveda-Beltran, MD |
| 9:33 a.m. |
16. Voriconazole Resistance Varies Across Fusarium Species Complexes in Isolates from the MUTT
Anisha Bhanot |
| 9:40 a.m. |
17. Correlation of Clinical Features and Outcome to Type of Fusarium Species
Bhupesh Bagga, FRCS |
| 9:47 a.m. |
18. Antiamoebic Susceptibility Differences of Acanthamoeba Cysts in Indian and US Isolates
Quintin Richardson |
| 9:54 a.m. |
OPEN QUESTIONS AND COMMENTS |
| 10:00 a.m. |
BREAK |
| 10:10 a.m. |
19. Topical Steroids to The Superior Bulbar Conjunctiva for The Treatment of Superior Limbic Keratoconjunctivitis (SLK)
Kelly A. Kiser, MD |
| 10:17 a.m. |
20. Sjögren’s Syndrome and Composition of the Gut Microbiome
Divy Mehra, BS |
| 10:24 a.m. |
21. Caspase-1 As A Biomarker of Ocular Surface Damage
Arianna Tovar, MD |
| 10:31 a.m. |
22. Automated Quantification of Activated Dendritic Cells in Central Cornea
Harry Levine, BA, BS |
| 10:38 a.m. |
23. Intraocular Inflammasome Activation in Corneal Graft Failure
Andres Serrano, MD |
| 10:45 a.m. |
24. Abstract Withdrawn
|
| 10:52 a.m. |
25. Conjunctival Papilloma Treatment Outcomes: A 12-Year-Retropsective Study
Wathanee Sripawadkul, MD |
| 10:59 a.m. |
OPEN QUESTIONS AND COMMENTS |
| 11:05 a.m. |
BREAK |
| 11:15 a.m. |
Thygeson Lecture: “Targeting Innate Immune Pathways in Bacterial Endophthalmitis?”
Michelle C. Callegan, PhD, FARVO
Director of Vision Research,
Dean A. McGee Eye Institute
Dean A. McGee Endowed Chair in Ophthalmology
George Lynn Cross Research Professor,
and Professor, Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center |
| 12:00 p.m. |
Closing Comments and Awards |
| 12:15 p.m. |
Business Luncheon |
